Patent · US Expired

Pyrimidine derivatives

US6908920B2 · kind B2 · utility

80Cited by
7References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 6, 2001
Grant dateJun 21, 2005
Priority date—
Expiry dateJul 6, 2021

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D403/12
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compounds of formula (I), wherein R1, p, R2, q, R3 and R4 are defined within, and a pharmaceutically acceptable salts and in vivo hydrolysable esters are described. Also described are processes for their preparation and their use as medicaments, particularly medicaments for producing a cell cycle inhibitory (anti-cell-proliferation) effect in a warm-blooded animal, such as man

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.